ArticleJournal of global health2017
Diabetes in Shenzhen, China: epidemiological investigation and health care challenges.
Article in Journal of global health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.
- The worldwide trend in diabetes awareness, treatment, and control from 1985 to 2022: a systematic review and meta-analysis of 233 population-representative studies.Frontiers in public health · 2024Pooled it
- Association between follow-up visit frequency, medication types prescribed, and glycaemic outcomes among diabetic patients in China's Basic Public Health Services programme: a retrospective cohort study.BMJ public health · 2025Article
- Exposure to Polybrominated Diphenyl Ethers and Phthalates in China: A Disease Burden and Cost Analysis.Toxics · 2022Article
- Glycemic control and its influencing factors in type 2 diabetes patients in Anhui, China.Frontiers in public health · 2022Article
- Prevalence and potential risk factors of self-reported diabetes among elderly people in China: A national cross-sectional study of 224,142 adults.Frontiers in public health · 2022Article
- Effect of Exposure to Paternal Smoking on Overweight and Obesity in Children: Findings from the Children Lifeway Cohort in Shenzhen, Southern China.Obesity facts · 2022Article
- Predictors of Undiagnosed Diabetes among Middle-Aged and Seniors in China: Application of Andersen's Behavioral Model.International journal of environmental research and public health · 2021Article
- CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients.European journal of clinical pharmacology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUnderstanding epidemiological characteristics of diabetes in a specific population will potentially benefit prevention and control of diabetes and policy-making. This study aimed to investigate the prevalence and awareness of diabetes, as well as its pharmacological, non-pharmacological and primary care management in Shenzhen, China.
methodsA cross-sectional study was conducted. We employed multistage cluster random sampling methods to select the participants. Face-to-face interview surveys were conducted to collect data. A total of 1676 participants completed the survey.
resultsWe found that the prevalence of diabetes was 4.8%. The prevalence of impaired fasting blood glucose was 6.0%. The prevalence rates of both diabetes and impaired fasting blood glucose increased with age (
conclusionsAlthough diabetes prevalence in Shenzhen is about a half that of the Chinese average, high prevalence of impaired fasting blood glucose imposes a public health threat and burden to the health care system. Approximately half of the subjects with diabetes are undiagnosed. Our findings highlight the need of public health efforts for primary and secondary prevention, as well as early detection of diabetes. Primary care may be crucial an improved access to medical services and better management of diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.